As an investigational peptide, any legitimate clinical use involves a licensed provider, a prescription, and compounding through a licensed pharmacy
Parking is easy, with ample parking available in our lot
Handling: Follow standard laboratory safety protocols
Tablets and capsules contain binders, fillers, coatings, and preservatives that can irritate the gastric mucosa or trigger sensitivity reactions in some people
It is recommended to check Hematocrit, reticulocyte count, vitamin B12, folate, and iron levels before treatment begins
Common side effects include: Injection site reactions mild pain, redness, swelling, or bruising at the injection site, typically resolving within a few days Headache usually transient and manageable with standard analgesia Nausea or dizziness particularly in the initial treatment phase Skin reactions including itching, mild rash, or acneiform eruptions Temporary urine discolouration red or orange urine is harmless and expected Diarrhoea or flushing usually mild and self-limiting In patients with severe megaloblastic anaemia, low potassium levels (hypokalaemia) may occur during initial intensive treatment, but this is uncommon in routine maintenance therapy
